Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
discontinue at least 2 months before planned conception per label guidance)
GLP-1 Market Share, By Drug Class, 2025 (%) The triple agonists (Pipeline) segment held a 3% share of the market in 2025 and is expected to grow at the fastest CAGR of 29.4% during the projection period
References to Wegovy, Ozempic, Rybelsus, Mounjaro, or Saxenda, or other GLP-1 brands, are informational only
Medication available separately via NovaCare for $499/month
TrimRx Idaho follows strict safety standards, ensuring your compounded semaglutide and semaglutide shots come from verified pharmacies
US$ 28.42
US$ 26.81
US$ 24.63
US$ 23.79
US$ 24.34
